Clinical trials for Carcinoma of the anal canal
13 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGN/ANCT07029152Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure ProphylaxisUniversitair Ziekenhuis Brussel
- ACTIVE NOT RECRUITINGPhase 3NCT06866574A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese MalesXiamen University · PI: Jun Zhang, Master
- RECRUITINGPhase 2NCT06640283Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical OutcomesInstituto do Cancer do Estado de São Paulo · PI: Maria DP Estevez Diz, Doctor
- RECRUITINGN/ANCT06792604Host Genome Methylation: a Screening Tool in Anal Cancer DetectionAssistance Publique - Hôpitaux de Paris
- RECRUITINGPhase 3NCT06207981Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCAFederation Francophone de Cancerologie Digestive · PI: Veronique Vendrely, Md-pHD
- RECRUITINGPhase 2NCT05661188Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)Grupo Espanol Multidisciplinario del Cancer Digestivo · PI: Jaume Capdevila
- RECRUITINGNCT06327568Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal SpecimensEuropean Institute of Oncology
- RECRUITINGNCT05438836Re-optimization Based Online Adaptive Radiotherapy of Anal CancerHerlev Hospital · PI: Eva S Serup-Hansen, MD, PhD
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04432597HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated CancersNational Cancer Institute (NCI) · PI: Charalampos Floudas, M.D.
- ACTIVE NOT RECRUITINGPhase 2NCT04166318Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE StudyECOG-ACRIN Cancer Research Group · PI: Jennifer A Dorth
- ACTIVE NOT RECRUITINGNCT03712566Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic TherapyUniversity Health Network, Toronto · PI: Elena Elimova, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03403465Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal CancersDuke University · PI: Junzo Chino, MD
- ACTIVE NOT RECRUITINGPhase 2NCT02314169Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal CancerNational Cancer Institute (NCI) · PI: Cathy Eng